查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092243

人工智慧在醫療診斷領域的市場－2026-2032年全球市場預測

Artificial Intelligence in Healthcare Diagnosis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療診斷領域的人工智慧 (AI) 市場規模將成長至 32.4 億美元，複合年成長率為 9.95%。

主要市場統計數據
基準年 2025 16.7億美元
預計年份：2026年 18.3億美元
預測年份 2032 32.4億美元
複合年成長率 (%) 9.95%

人工智慧在醫學診斷領域的應用正從實驗性決策支援轉向整合到放射學、病理學、循環系統、腫瘤學、眼科、基因組學、急診醫學和公共衛生等臨床基礎設施。這項技術能夠從醫學影像、檢驗結果、電子健康記錄、穿戴式裝置資料和複雜的病患病歷中，大規模、持續地識別難以辨別的模式，進而輔助臨床醫師。已證實的臨床應用案例包括：影像學中的電腦輔助檢測、中風和肺動脈栓塞診支持、糖尿病視網膜病變篩檢、膿毒症風險預警、心電圖解讀、臨床病歷創建支持以及診斷流程最佳化。推動這項應用的因素包括：慢性病負擔日益加重、人口老化、臨床醫生短缺、診斷延誤、減少診斷錯誤的努力以及改善醫療資源匱乏地區就醫需求等諸多切實存在的醫學挑戰。儘管主要司法管轄區的監管機構已經批准或授權了許多人工智慧醫療設備，尤其是在放射學和心血管診斷領域，但醫療系統在擴大部署之前，越來越要求獲得有關安全性、偏見、互通性、工作流程影響、網路安全和臨床結果的證據。因此，目前人工智慧在醫療診斷領域的應用現狀不僅取決於演算法效能，還取決於可靠性、可解釋性、資料管治、報銷相容性以及與臨床醫生主導的醫療模式的整合。

一場變革性的變革，重塑了診斷人工智慧。

多模態資料融合、雲端運算、邊緣部署、醫學影像數位化、可互通的醫療記錄以及基礎模型​​的進步正在改變著當前診斷人工智慧的現狀。傳統的單任務演算法正日益被能夠支持更具情境性的診斷推理的系統所補充，這些系統透過整合放射影像、病理切片、實驗室數值、基因組資訊、臨床記錄以及患者長期數據來實現這一目標。另一個重大轉變是從演算法的回顧性檢驗轉向前瞻性臨床評估。因此，醫療機構目前正在評估人工智慧如何在真實臨床環境中改變診斷時間、轉診準確性、臨床醫生工作量、假陽性率以及患者預後。監管機構的期望也在發生變化，他們越來越關注軟體生命週期管理、上市後監管、模型漂移、人工監督以及訓練資料和預期用途的透明度。醫療服務提供者優先考慮能夠整合到現有臨床工作流程中的人工智慧工具，而不是獨立的應用程式，而保險公司和政策制定者則在仔細審查有關臨床效用和成本效益的證據。此外，隨著各組織機構考慮人口統計偏差、數據代表性、知情同意、隱私、網路安全和課責等問題，產業趨勢正朝著「負責任的人工智慧」方向轉變。這種轉變正在加速對經過臨床檢驗、互通性、可審計且旨在實現安全的人機協作的診斷人工智慧解決方案的需求。

人工智慧對診斷的累積影響

人工智慧在醫學診斷領域的累積影響體現在速度、一致性、可及性和臨床決策品質等。人工智慧輔助診斷可以幫助優先處理緊急病例，識別細微異常，減少重複性審查工作，並在高流量環境下規範診斷觀察的解讀。在影像檢查密集型專科領域，人工智慧可以輔助分診隊列，並透過觀察疑似顱內出血、肺結節、骨折、乳房病變或心血管異常，幫助臨床醫師快速檢視診斷結果。在基層醫療和慢性病管理領域，人工智慧可以透過分析常規數據並識別與糖尿病併發症、心血管疾病、腎臟疾病、癌症風險和感染疾病加重相關的風險訊號，從而增強早期檢測能力。在病理學和基因組學領域，人工智慧驅動的影像分析和模式識別可以支援精準診斷，同時幫助臨床醫生更有效率地處理複雜的資料集。然而，其累積價值取決於規範的實施。整合不當的人工智慧可能會加劇警報疲勞，引入自動化偏差，或在訓練資料集代表性不足的人群中無法達到預期效果。因此，醫療機構正轉向實證管治、持續績效監控、臨床醫師培訓和多學科審查。診斷人工智慧在提高工作流程可靠性、支援早期療育和增強臨床醫生信心方面最為有效，而不是取代專家判斷。

區域層面關於人工智慧在全球診斷領域應用的關鍵見解

亞太地區正崛起為人工智慧在醫療診斷領域的中心，這得益於對數位醫療的快速投資、龐大的患者都市區、不斷擴展的醫療影像基礎設施以及支援人工智慧和醫療數據現代化的國家戰略。在亞太地區各國，人工智慧已被應用於放射學分診、結核病篩檢、糖尿病視網膜病變檢測、癌症診斷和遠端醫療服務，尤其是在城鄉地區專科醫生資源匱乏的地區。北美地區人工智慧應用蓬勃發展，這得益於電子健康記錄的廣泛普及、完善的醫院網路、成熟的醫療設備法規、學術臨床檢驗計畫以及人工智慧驅動的影像和臨床決策支援工具的廣泛部署。在美國和加拿大，演算法透明度、醫療資料隱私和實際效能監測也備受重視。在拉丁美洲，診斷人工智慧的應用案例正在開發中，重點在於擴展遠端醫療、影像服務、傳染病篩檢和慢性病管理，而互通性和基礎設施差異是影響其應用的關鍵因素。歐洲擁有嚴格的資料保護要求、醫療設備法規、跨境研究網路和健全的公共衛生體系，因此對可解釋、經臨床檢驗且符合倫理規範的人工智慧有著迫切的需求。在中東，隨著醫療現代化進程的推進，對數位化醫院、國家人工智慧策略和先進診斷技術的投資也在增加，這促使人們對放射學、基因組學和預防性篩檢的興趣日益濃厚。在非洲，診斷人工智慧的發展機會與擴大醫療服務覆蓋範圍、行動醫療醫療、感染疾病檢測、孕產婦保健以及緩解勞動力短缺密切相關，而其成功實施取決於通訊基礎設施、本地檢驗、可負擔性以及與醫療專業人員的合作。

戰略醫療保健部門的關鍵群體洞察

在東協，人工智慧在醫療診斷領域的應用正隨著數位化醫療轉型、遠端醫療發展、公私合營進行臨床創新以及不同醫療體系對高度擴充性診斷工具的需求而不斷推進。在島嶼、城市和農村地區專科醫生分佈不均的地區，人工智慧驅動的結核病、糖尿病眼科疾病、癌症篩檢和放射學篩檢尤其重要。都市區合作委員會（GCC）國家正將人工智慧驅動的醫療保健作為其國家數位轉型計畫的優先事項，並對智慧醫院、精準醫療、診斷影像、人口健康分析和預防醫學表現出濃厚的興趣。歐盟正透過監管協調、加強健康數據管治、醫療設備監管以及關注可信賴的人工智慧來塑造診斷人工智慧，並將合規性、可解釋性、風險管理和資料保護作為其應用的核心。金磚國家擁有龐大的患者群體、日益加重的慢性病負擔、不斷擴展的數位基礎設施以及政府對人工智慧驅動的公共衛生的高度重視，這些都為診斷人工智慧的發展提供了廣闊的機會。然而，具體實施方案因醫療體系、資料標準化程度和當地法規成熟度而異。七國集團（G7）憑藉著完善的醫療體系和雄厚的研究實力，正積極推動關於人工智慧輔助診斷的先進臨床檢驗、監管科學、網路安全框架和保險報銷等方面的討論。北約成員國雖然並非醫療衛生集團，但在安全數位基礎設施、網路安全、韌性和可靠的技術供應鏈等方面擁有通用的政策，這些因素都會影響診斷人工智慧在醫院、軍事醫療體系、緊急應變和跨境衛生安全等領域的安全部署。

主要國家人工智慧輔助醫療診斷的發展趨勢

美國是人工智慧在醫療診斷領域應用最活躍的國家之一，這得益於其豐富的已經過核准的人工智慧醫療設備、先進的影像網路、電子健康記錄記錄基礎設施以及活躍的臨床研究。優先應用領域包括放射學、循環系統、腫瘤學、中風分診以及文件輔助診斷工作流程。在加拿大，公共資助的醫療保健體系強調循證部署、隱私保護和人工智慧管治，人工智慧正擴大應用於影像、遠距離診斷和人群健康分析。在墨西哥，隨著醫療保健的數位化程度不斷提高，人工智慧在診斷、遠端醫療、慢性病篩檢和放射學輔助方面的重要性日益凸顯。在巴西，在大規模臨床資料集和不斷擴展的數位健康舉措的支持下，人工智慧診斷技術正在影像學、眼科學、腫瘤學和公共衛生監測領域取得進展。英國致力於在國家醫療服務體系 (NHS) 內，按照相關法規部署經臨床評估的人工智慧，並積極推進影像網路建設、最佳化癌症治療流程以及產生真實世界證據。德國的診斷人工智慧環境得益於醫院數位化舉措、強大的醫療技術能力以及對資料保護和互通性的重視。法國正在推動人工智慧在放射學、病理學、罕見疾病診斷和健康數據平台中的應用，同時強調倫理和監管控制。俄羅斯正在推動人工智慧在醫學影像和公共部門診斷舉措中的應用，尤其是在支持放射科工作流程方面。義大利和西班牙正在將人工智慧應用於影像學、腫瘤學、循環系統以及改善醫院工作流程，其具體實施方案受到區域醫療保健系統結構和歐洲監管要求的影響。在中國，由於大量資料的可用性、國家人工智慧優先政策以及數位化醫院的快速發展，診斷人工智慧的應用正在影像學、眼科學、病理學以及整體醫院工作流程中不斷擴展。在印度，由於專科醫生短缺、疾病負擔沉重，以及結核病、糖尿病視網膜病變、放射學和基層醫療等領域亟需大規模篩檢，人工智慧輔助診斷被認為至關重要。日本憑藉其先進的醫療基礎設施，正利用人工智慧來應對老化帶來的醫療需求，改善影像、內視鏡和循環系統檢查，並簡化工作流程。澳洲正透過臨床檢驗、遠端醫療、影像診斷支援以及支援跨越廣大地域的醫療服務所取得的管治框架，推動診斷人工智慧的發展。韓國擁有強大的數位基礎設施、醫院層面的技術應用以及人工智慧研究能力，其應用案例涵蓋放射學、病理學、腫瘤學和精準診斷等眾多領域。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的人工智慧解決方案，以解決影響巨大的診斷瓶頸問題，例如影像診斷延遲、專家會診延遲、慢性病篩檢延遲以及急診分流延遲。實施應從明確定義的用例、可衡量的臨床終點、工作流程圖和基準效能評估開始。各機構應建立一個跨學科的管治框架，涵蓋臨床醫生、資料科學家、合規團隊、網路安全專家、病患代表和營運經理。診斷人工智慧的評估應從靈敏度、特異性、假陽性率、亞組性能、模型漂移、易用性、警報疲勞以及對臨床醫生決策的影響等方面進行。領導者必須確保與電子健康記錄、影像歸檔和通訊系統 (PACS)、實驗室系統和臨床文件工作流程的互通性，以避免部署碎片化。強大的資料管治至關重要，包括隱私保護、審計追蹤、存取控制、知情同意的完整性以及網路安全彈性。醫療系統應投資於臨床醫生的培訓，以減少自動化偏見，並確保人工智慧始終是輔助工具，而不是不受控制的決策者。為了實現可擴展的部署，領導者應建立部署後監測計劃，追蹤實際應用中的效能、公平性、病患安全和營運結果。與學術機構、監管機構和醫療保健網路夥伴關係，可以加強外部檢驗，並加速在不同患者群體中負責任地部署。

診斷人工智慧的調查方法

用於分析人工智慧在醫療診斷領域應用的調查方法應結合檢驗的二手研究、監管審查、臨床證據評估以及基於專家見解的解釋。可靠的資訊來源包括同儕審查的臨床研究、系統綜述、人工智慧醫療設備監管資料庫、公共衛生出版物、醫院數位轉型出版刊物、標準化機構指南以及政府關於人工智慧、醫療軟體、網路安全和健康數據管治的政策文件。評估應著重於臨床效用而非市場標語，檢驗人工智慧工具是否能提高診斷準確性、縮短診斷時間、提升分流效率、提高工作流程效率、促進早期發現、改善就醫途徑或改善病患預後。證據評估應從研究設計品質、樣本多樣性、前瞻性檢驗、外部檢驗、亞組分析和實際應用經驗等方面進行。區域和國家層面的洞察應透過政策分析、數位健康成熟度指標、醫療基礎設施趨勢、疾病負擔數據和法規環境來獲得。為保持客觀性，調查方法必須避免檢驗的說法，並排除推測性的市場規模、市場佔有率或預測。不斷更新證據至關重要，因為診斷人工智慧的效能會隨著新資料集、臨床工作流程、軟體更新和不斷變化的監管要求而波動。

結論：建立可靠的醫療診斷人工智慧。

人工智慧在醫學診斷領域正成為實現更快、更一致、更方便的臨床決策支援的關鍵要素。其最大價值在於透過提昇模式識別、循環系統優先排序和診斷工作流程效率，增強臨床醫生在影像學、病理學、心臟病學、眼科學、腫瘤學、基因組學和基層醫療等領域的能力。全球範圍內人工智慧的普及應用受到醫療數位化、監管審查、數據管治期望以及在人力資源和醫療能力緊張的情況下對早期疾病檢測的需求等因素的影響。儘管不同地區和國家的基礎設施、政策成熟度、臨床檢驗能力和應用需求各不相同，但發展方向始終如一：診斷人工智慧必須安全、透明、可互通、公平且具有臨床意義。那些能夠平衡可靠的證據產生和負責任的部署的機構，將更有利於在診斷品質和患者照護取得可衡量的進步。人工智慧在醫療診斷領域的未來，與其說是取決於演算法本身的新穎性，不如說是取決於其可靠性、在真實臨床環境中的表現、倫理管治以及與臨床醫生主導的醫療保健服務的無縫整合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人工智慧在醫療診斷領域的市場：按模式分類

  • 臨床記錄
  • 電子健康記錄
    • 結構化資料
    • 非結構化數據
      • 臨床教科書
      • 檢查報告
  • 基因組數據
  • 診斷影像
    • 電腦斷層掃描
    • 磁振造影
    • 正子斷層掃描
    • X光
    • 超音波
  • 穿戴式裝置數據

第8章：醫療診斷領域的人工智慧市場：按技術分類

  • 電腦視覺
  • 深度學習
  • 機器學習
    • 強化學習
    • 監督式學習
    • 無監督學習
  • 自然語言處理

第9章：人工智慧在醫療診斷領域的市場：按應用分類

  • 疾病識別
    • 癌症篩檢
    • 心血管分析
    • 感染疾病檢測
    • 神經病變
    • 整形外科評估
  • 風險預測
    • 癌症風險預測
    • 心血管風險預測
    • 糖尿病風險預測
    • 預測再入院率
  • 症狀評估
  • 治療方案提案

第10章：醫療診斷領域的人工智慧市場：按部署模式分類

  • 基於雲端的
    • 混合雲端
    • 私有雲端
    • 公共雲端
  • 現場

第11章：醫療診斷領域的人工智慧市場：按最終用戶分類

  • 診斷檢查室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 醫療IT公司
  • 醫院和診所
    • 大型醫院
    • 中小型診所
  • 病人

第12章：醫療診斷領域的人工智慧市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：醫療診斷領域的人工智慧市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人工智慧在醫療診斷領域的市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agfa-Gevaert NV
  • Aidoc Medical Ltd
  • Aiforia Technologies Plc
  • Butterfly Network Inc
  • Canon Medical Systems Corporation
  • Cleerly Inc
  • CureMetrix Inc
  • Enlitic Inc
  • Fujifilm Holdings Corporation
  • GE Healthcare, Inc.
  • HeartFlow Inc
  • Ibex Medical Analytics Ltd
  • International Business Machines Corporation
  • Koninklijke Philips NV
  • Lunit Inc
  • NVIDIA Corporation
  • Oxipit UAB
  • Paige.AI Inc
  • Palantir Technologies Inc.
  • Proscia Inc
  • Quibim SL
  • Qure.ai Technologies Pvt Ltd
  • Siemens Healthineers AG
  • Subtle Medical Inc
  • Tempus AI Inc
  • Thermo Fisher Scientific Inc.
  • Viz.ai Inc
Product Code: MRR-4103B31E04F5

The Artificial Intelligence in Healthcare Diagnosis Market is projected to grow by USD 3.24 billion at a CAGR of 9.95% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.67 billion
Estimated Year [2026] USD 1.83 billion
Forecast Year [2032] USD 3.24 billion
CAGR (%) 9.95%

Artificial intelligence in healthcare diagnosis is moving from experimental decision support toward embedded clinical infrastructure across radiology, pathology, cardiology, oncology, ophthalmology, genomics, emergency care, and population health. The technology supports clinicians by detecting patterns in medical images, laboratory results, electronic health records, wearable data, and multimodal patient histories that may be difficult to identify consistently at scale. Verified clinical use cases include computer-aided detection in imaging, triage support for stroke and pulmonary embolism, diabetic retinopathy screening, sepsis risk alerts, electrocardiogram interpretation, clinical documentation support, and diagnostic pathway optimization. Adoption is being shaped by measurable healthcare pressures: rising chronic disease burden, aging populations, clinician shortages, delayed diagnosis, diagnostic error reduction initiatives, and the need to improve access in underserved settings. Regulatory bodies in major jurisdictions have already cleared or authorized numerous AI-enabled medical devices, particularly in radiology and cardiovascular diagnostics, while health systems increasingly require evidence on safety, bias, interoperability, workflow impact, cybersecurity, and clinical outcomes before scaling deployment. As a result, the AI in healthcare diagnosis landscape is defined not only by algorithmic performance, but also by trust, explainability, data governance, reimbursement alignment, and integration into clinician-led care models.

Transformative Shifts Reshaping Diagnostic AI

The diagnostic AI landscape is being transformed by the convergence of multimodal data, cloud-enabled computing, edge deployment, medical imaging digitization, interoperable health records, and advances in foundation models. Traditional single-task algorithms are increasingly being complemented by systems that can combine radiology images, pathology slides, laboratory values, genomics, clinical notes, and longitudinal patient data to support more contextual diagnostic reasoning. Another major shift is the movement from retrospective algorithm validation to prospective clinical evaluation, where healthcare organizations assess whether AI changes time-to-diagnosis, referral accuracy, clinician workload, false positive rates, and patient outcomes in real-world settings. Regulatory expectations are also evolving, with increased focus on software lifecycle management, post-market monitoring, model drift, human oversight, and transparency across training data and intended use. Healthcare providers are prioritizing AI tools that fit into existing clinical workflows rather than standalone applications, while payers and policymakers are scrutinizing evidence of clinical utility and cost-effectiveness. The landscape is also shifting toward responsible AI, as institutions examine demographic bias, data representativeness, consent, privacy, cybersecurity, and accountability. These changes are accelerating demand for diagnostic AI solutions that are clinically validated, interoperable, auditable, and designed for safe human-AI collaboration.

Cumulative Impact of Artificial Intelligence on Diagnosis

The cumulative impact of artificial intelligence in healthcare diagnosis is visible across speed, consistency, access, and clinical decision quality. AI-enabled diagnostic support can help prioritize urgent cases, flag subtle abnormalities, reduce repetitive review tasks, and standardize interpretation across high-volume care environments. In imaging-heavy specialties, AI can support triage queues by identifying suspected intracranial hemorrhage, lung nodules, fractures, breast lesions, or cardiovascular abnormalities for faster clinician review. In primary care and chronic disease management, AI can strengthen early detection by analyzing routine data for risk signals related to diabetes complications, cardiovascular disease, kidney disease, cancer risk, and infection deterioration. In pathology and genomics, AI-assisted image analysis and pattern recognition are helping clinicians process complex datasets more efficiently while supporting precision diagnosis. However, cumulative value depends on disciplined implementation. Poorly integrated AI can increase alert fatigue, introduce automation bias, or underperform in populations not well represented in training datasets. Healthcare organizations are therefore shifting toward evidence-based governance, continuous performance monitoring, clinician training, and multidisciplinary review. The strongest impact emerges when diagnostic AI improves workflow reliability, supports earlier intervention, and enhances clinician confidence without replacing professional judgment.

Key Regional Insights Across Global Diagnostic AI Adoption

Asia-Pacific is emerging as a high-activity region for AI in healthcare diagnosis due to rapid digital health investment, large patient populations, expanding medical imaging infrastructure, and national strategies supporting artificial intelligence and health data modernization. Countries across the region are applying AI to radiology triage, tuberculosis screening, diabetic retinopathy detection, cancer diagnostics, and remote care delivery, particularly where specialist access is uneven between urban and rural areas. North America shows strong adoption momentum supported by mature electronic health record penetration, advanced hospital networks, established medical device regulation, academic clinical validation programs, and widespread deployment of AI-enabled imaging and clinical decision support tools. The United States and Canada are also emphasizing algorithm transparency, health data privacy, and real-world performance monitoring. Latin America is developing diagnostic AI use cases around telehealth expansion, imaging access, infectious disease screening, and chronic disease management, though interoperability and infrastructure variability remain important adoption factors. Europe is shaped by strict data protection requirements, medical device regulation, cross-border research networks, and strong public health systems, creating demand for explainable, clinically validated, and ethically governed AI. The Middle East is investing in digital hospitals, national AI strategies, and advanced diagnostics as part of healthcare modernization, with high interest in radiology, genomics, and preventive screening. Africa's diagnostic AI opportunities are closely linked to access expansion, mobile health, infectious disease detection, maternal health, and shortage mitigation, with successful deployment depending on connectivity, local validation, affordability, and health workforce integration.

Key Group Insights Across Strategic Healthcare Blocs

ASEAN is advancing AI in healthcare diagnosis through digital health transformation, telemedicine growth, public-private clinical innovation, and demand for scalable diagnostic tools across diverse healthcare systems. AI-supported screening for tuberculosis, diabetic eye disease, cancer, and radiology triage is particularly relevant where specialist distribution varies across island, urban, and rural populations. The GCC is prioritizing AI-enabled healthcare as part of national digital transformation agendas, with strong interest in smart hospitals, precision medicine, imaging diagnostics, population health analytics, and preventive care. The European Union is shaping diagnostic AI through harmonized regulation, health data governance initiatives, medical device oversight, and an emphasis on trustworthy AI, making compliance, explainability, risk management, and data protection central to adoption. BRICS countries collectively represent a broad diagnostic AI opportunity because of large patient populations, growing chronic disease burdens, expanding digital infrastructure, and government interest in AI-enabled public health; however, deployment conditions vary widely by healthcare capacity, data standardization, and local regulatory maturity. G7 countries are driving advanced clinical validation, regulatory science, cybersecurity frameworks, and reimbursement discussions for AI-assisted diagnosis, supported by established health systems and significant research capacity. NATO countries, while not a healthcare bloc, share policy relevance around secure digital infrastructure, cybersecurity, resilience, and trusted technology supply chains, all of which influence the safe adoption of diagnostic AI in hospitals, military health systems, emergency response, and cross-border health security contexts.

Key Country Insights in AI-Enabled Healthcare Diagnosis

The United States is one of the most active environments for AI in healthcare diagnosis, supported by a large base of authorized AI-enabled medical devices, advanced imaging networks, electronic health record infrastructure, and strong clinical research activity, with priority areas including radiology, cardiology, oncology, stroke triage, and documentation-assisted diagnostic workflows. Canada emphasizes evidence-based adoption, privacy safeguards, and AI governance within publicly funded care pathways, with applications in imaging, remote diagnostics, and population health analytics. Mexico is seeing relevance for AI in diagnostic access, telehealth, chronic disease screening, and radiology support as healthcare digitization progresses. Brazil is advancing AI-enabled diagnostics in imaging, ophthalmology, oncology, and public health surveillance, supported by large clinical datasets and growing digital health initiatives. The United Kingdom is focused on regulated, clinically evaluated AI adoption within national health services, with strong activity in imaging networks, cancer pathway optimization, and real-world evidence generation. Germany's diagnostic AI environment benefits from hospital digitization initiatives, strong medical technology capabilities, and attention to data protection and interoperability. France is advancing AI in radiology, pathology, rare disease diagnostics, and health data platforms while emphasizing ethical and regulatory controls. Russia has pursued AI applications in medical imaging and public-sector diagnostic initiatives, particularly in radiology workflow support. Italy and Spain are applying AI to imaging, oncology, cardiology, and hospital workflow improvement, with adoption shaped by regional health system structures and European regulatory requirements. China is scaling diagnostic AI across imaging, ophthalmology, pathology, and hospital workflow, supported by large data availability, national AI priorities, and rapid digital hospital development. India is highly relevant for AI-enabled diagnosis because of specialist shortages, high disease burden, and the need for scalable screening in tuberculosis, diabetic retinopathy, radiology, and primary care. Japan is applying AI to aging-related healthcare needs, imaging, endoscopy, cardiology, and workflow efficiency, supported by advanced medical infrastructure. Australia is advancing diagnostic AI through clinical validation, remote care, imaging support, and governance frameworks that address access across large geographic distances. South Korea combines strong digital infrastructure, hospital technology adoption, and AI research capacity, with use cases across radiology, pathology, oncology, and precision diagnostics.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated AI solutions that address high-impact diagnostic bottlenecks, such as imaging backlogs, delayed specialist review, chronic disease screening, and emergency triage. Implementation should begin with clearly defined intended use, measurable clinical endpoints, workflow mapping, and baseline performance assessment. Organizations should establish multidisciplinary governance involving clinicians, data scientists, compliance teams, cybersecurity specialists, patient representatives, and operational leaders. Diagnostic AI should be evaluated across sensitivity, specificity, false positive rates, subgroup performance, model drift, usability, alert fatigue, and impact on clinician decision-making. Leaders should require interoperability with electronic health records, picture archiving and communication systems, laboratory systems, and clinical documentation workflows to avoid fragmented adoption. Strong data governance is essential, including privacy protection, audit trails, access controls, consent alignment, and cybersecurity resilience. Health systems should invest in clinician education to reduce automation bias and ensure AI remains a support tool rather than an unchecked decision-maker. For scalable adoption, leaders should build post-deployment monitoring programs that track real-world performance, equity, patient safety, and operational outcomes. Partnerships with academic institutions, regulators, and healthcare networks can strengthen external validation and accelerate responsible deployment across diverse patient populations.

Research Methodology for Diagnostic AI Intelligence

The research methodology for analyzing artificial intelligence in healthcare diagnosis should combine verified secondary research, regulatory review, clinical evidence assessment, and expert-informed interpretation. Reliable inputs include peer-reviewed clinical studies, systematic reviews, regulatory databases for AI-enabled medical devices, public health authority publications, hospital digital transformation reports, standards organization guidance, and government policy documents on artificial intelligence, medical software, cybersecurity, and health data governance. Evaluation should focus on clinical utility rather than promotional claims, examining whether AI tools improve diagnostic accuracy, turnaround time, triage efficiency, workflow productivity, early detection, access, or patient outcomes. Evidence should be assessed across study design quality, sample diversity, prospective validation, external validation, subgroup analysis, and real-world deployment results. Regional and country-level insights should be developed through policy analysis, digital health maturity indicators, healthcare infrastructure trends, disease burden data, and regulatory conditions. To maintain objectivity, the methodology should avoid unverified claims and exclude speculative market sizing, market share, or forecasting. Continuous evidence updates are necessary because diagnostic AI performance can change with new datasets, clinical workflows, software updates, and evolving regulatory expectations.

Conclusion: Building Trustworthy AI for Healthcare Diagnosis

Artificial intelligence in healthcare diagnosis is becoming a critical enabler of faster, more consistent, and more accessible clinical decision support. Its strongest value lies in augmenting clinicians across imaging, pathology, cardiology, ophthalmology, oncology, genomics, and primary care by improving pattern recognition, triage prioritization, and diagnostic workflow efficiency. Global adoption is being shaped by healthcare digitization, regulatory scrutiny, data governance expectations, and the demand for earlier disease detection amid workforce and capacity pressures. Regions and countries differ in infrastructure, policy maturity, clinical validation capacity, and access needs, but the direction is consistent: diagnostic AI must be safe, transparent, interoperable, equitable, and clinically meaningful. Organizations that pair robust evidence generation with responsible implementation will be better positioned to achieve measurable improvements in diagnostic quality and patient care. The future of AI in healthcare diagnosis will depend less on algorithm novelty alone and more on trust, real-world performance, ethical governance, and seamless integration into clinician-led healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Healthcare Diagnosis Market, by Modality

  • 7.1. Introduction
  • 7.2. Clinical Notes
  • 7.3. Electronic Health Records
    • 7.3.1. Structured Data
    • 7.3.2. Unstructured Data
      • 7.3.2.1. Clinical Text
      • 7.3.2.2. Lab Reports
  • 7.4. Genomic Data
  • 7.5. Imaging
    • 7.5.1. Computed Tomography
    • 7.5.2. Magnetic Resonance Imaging
    • 7.5.3. Positron Emission Tomography
    • 7.5.4. Radiography
    • 7.5.5. Ultrasound
  • 7.6. Wearable Data

8. Artificial Intelligence in Healthcare Diagnosis Market, by Technology

  • 8.1. Introduction
  • 8.2. Computer Vision
  • 8.3. Deep Learning
  • 8.4. Machine Learning
    • 8.4.1. Reinforcement Learning
    • 8.4.2. Supervised Learning
    • 8.4.3. Unsupervised Learning
  • 8.5. Natural Language Processing

9. Artificial Intelligence in Healthcare Diagnosis Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Identification
    • 9.2.1. Cancer Screening
    • 9.2.2. Cardiovascular Analysis
    • 9.2.3. Infectious Disease Detection
    • 9.2.4. Neurological Disorders
    • 9.2.5. Orthopedic Assessment
  • 9.3. Risk Prediction
    • 9.3.1. Cancer Risk Prediction
    • 9.3.2. Cardiovascular Risk Prediction
    • 9.3.3. Diabetes Risk Prediction
    • 9.3.4. Hospital Readmission Prediction
  • 9.4. Symptom Assessment
  • 9.5. Treatment Recommendation

10. Artificial Intelligence in Healthcare Diagnosis Market, by Deployment Mode

  • 10.1. Introduction
  • 10.2. Cloud Based
    • 10.2.1. Hybrid Cloud
    • 10.2.2. Private Cloud
    • 10.2.3. Public Cloud
  • 10.3. On Premise

11. Artificial Intelligence in Healthcare Diagnosis Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital Based Laboratories
    • 11.2.2. Independent Laboratories
  • 11.3. Healthcare IT Companies
  • 11.4. Hospitals & Clinics
    • 11.4.1. Large Hospitals
    • 11.4.2. Small & Medium Clinics
  • 11.5. Patients

12. Artificial Intelligence in Healthcare Diagnosis Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Artificial Intelligence in Healthcare Diagnosis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Intelligence in Healthcare Diagnosis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agfa-Gevaert N.V.
  • 16.2. Aidoc Medical Ltd
  • 16.3. Aiforia Technologies Plc
  • 16.4. Butterfly Network Inc
  • 16.5. Canon Medical Systems Corporation
  • 16.6. Cleerly Inc
  • 16.7. CureMetrix Inc
  • 16.8. Enlitic Inc
  • 16.9. Fujifilm Holdings Corporation
  • 16.10. GE Healthcare, Inc.
  • 16.11. HeartFlow Inc
  • 16.12. Ibex Medical Analytics Ltd
  • 16.13. International Business Machines Corporation
  • 16.14. Koninklijke Philips N.V.
  • 16.15. Lunit Inc
  • 16.16. NVIDIA Corporation
  • 16.17. Oxipit UAB
  • 16.18. Paige.AI Inc
  • 16.19. Palantir Technologies Inc.
  • 16.20. Proscia Inc
  • 16.21. Quibim SL
  • 16.22. Qure.ai Technologies Pvt Ltd
  • 16.23. Siemens Healthineers AG
  • 16.24. Subtle Medical Inc
  • 16.25. Tempus AI Inc
  • 16.26. Thermo Fisher Scientific Inc.
  • 16.27. Viz.ai Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL NOTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL NOTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL NOTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELECTRONIC HEALTH RECORDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELECTRONIC HEALTH RECORDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELECTRONIC HEALTH RECORDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURED DATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURED DATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURED DATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UNSTRUCTURED DATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UNSTRUCTURED DATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UNSTRUCTURED DATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TEXT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TEXT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TEXT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LAB REPORTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LAB REPORTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LAB REPORTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GENOMIC DATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GENOMIC DATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GENOMIC DATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WEARABLE DATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WEARABLE DATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WEARABLE DATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPUTER VISION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPUTER VISION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPUTER VISION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DEEP LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DEEP LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DEEP LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REINFORCEMENT LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REINFORCEMENT LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REINFORCEMENT LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DISEASE IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DISEASE IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DISEASE IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOVASCULAR ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIOVASCULAR ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIOVASCULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INFECTIOUS DISEASE DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INFECTIOUS DISEASE DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INFECTIOUS DISEASE DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ORTHOPEDIC ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ORTHOPEDIC ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ORTHOPEDIC ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RISK PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RISK PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RISK PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CANCER RISK PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CANCER RISK PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CANCER RISK PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIOVASCULAR RISK PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIOVASCULAR RISK PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIOVASCULAR RISK PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIABETES RISK PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIABETES RISK PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIABETES RISK PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOSPITAL READMISSION PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOSPITAL READMISSION PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITAL READMISSION PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SYMPTOM ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SYMPTOM ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SYMPTOM ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TREATMENT RECOMMENDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TREATMENT RECOMMENDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TREATMENT RECOMMENDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOSPITAL BASED LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOSPITAL BASED LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOSPITAL BASED LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEALTHCARE IT COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEALTHCARE IT COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEALTHCARE IT COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LARGE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LARGE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LARGE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SMALL & MEDIUM CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SMALL & MEDIUM CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SMALL & MEDIUM CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY RISK PREDICTION, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY ELECTRONIC HEALTH RECORDS, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY UNSTRUCTURED DATA, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 306. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 308. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY DISEASE IDENTIFICATION, 2018-2032 (USD MILLIO